Identity
- Security key
- 15148
- Ticker
- FBLG
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-01-31
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- FBLG
Detail
Enriched 2026-08-14 20:47
- Market cap
- $7,390,594.23
- Shares outstanding (class)
- 6,658,193
- Shares outstanding (weighted)
- 6,658,193
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 15
- Location
- HOUSTON, TX
- Homepage
- https://www.fibrobiologics.com
- Description
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.